Production of Pilot Scale Libraries of Marine Natural Products
Production of Pilot Scale Libraries of Marine Natural Products
批准号:
8247697
负责人:
AMY Elizabeth WRIGHT
金额:
$35.22万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-05 至 2014-03-31
关键词:
AffectAlgaeBiologicalBiological FactorsBiological ProcessChemicalsChloroformCnidariaCollectionComplexDimethyl SulfoxideDiversity LibraryEnvironmentFractionationFreezingGenerationsGoalsHealthHumanLeadLibrariesLiquid ChromatographyMarinesMethanolMethodsMolecularMolecular BankOrganismPoriferaProductionRelative (related person)ResearchResearch Project GrantsScienceScreening procedureSolubilityStructureWaterascidianhigh throughput screeningmarine natural productmarine organismmeetingsnovelpressurepublic health relevancerepositorysmall molecule
中文摘要
描述(由申请人提供):该项目的目标是通过向分子库小分子库(MLSMR)提供每年10-25种新颖或稀有、结构复杂的海洋天然产物的中试规模库(PSL),扩大分子库探针生产中心网络(MLPCN)可用的化学多样性。这些化合物将来自HBOI冷冻生物储存库中的海洋大型生物,包括海绵,海鞘,刺胞动物和藻类,重点是从不易进入的深水海洋环境中收集的生物。该项目的主要重点将是提供科学上结构新颖的化合物,但除此之外,还将提供MLSMR目前无法获得的具有不寻常结构的稀有天然产品。提供的所有化合物将满足MLSMR的标准,即10 mg,> 90%纯度和在氯仿:甲醇9:1或DMSO中的溶解度。HBOI拥有超过15,000种海洋生物的特殊收藏,可用于产生中试规模的图书馆,其中许多生物是HBOI收藏的独特生物。我们的研究小组最近进行了一个项目,以创建一个与高通量筛选兼容的富集级分的“峰库”,在检测过去没有进行化学研究的生物体中的不寻常化学型方面非常成功。峰库中的大多数馏分仅需要一个额外的纯化步骤即可提供纯物质,初始分级(中压液相色谱)的规模可轻松分离出大量物质。我们最近扩展了HBOI筛选平台,并观察到在Peak Library中发现的许多新型化学型影响独特的生物靶标,并代表了用于研究生物过程的新型先导结构和优秀探针。我们将建立在用于生产我们的峰值库的方法上,以创建一个独特的不寻常的纯天然产品的中试规模库,扩大MLSMR中目前可用的化学多样性空间。
公共卫生相关性:拟议的研究项目将为分子库小分子库提供一个独特的新的和稀有的天然产物的中试规模库,并扩大库的化学多样性。这将提高分子路线图的机会,以满足他们的目标,发现新的探针的生物机制,以及化合物与独特的生物活性相对于人类健康。
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is expand the chemical diversity available to the Molecular Library Probe Production Center Network (MLPCN) by providing the Molecular Libraries Small-Molecule Repository (MLSMR) a pilotscale library (PSL) of 10-25, novel or rare, structurally complex marine natural products per year. The compounds will be derived from marine macro-organisms in the HBOI Frozen Organism Repository including sponges, ascidians, cnidarians, and algae with an emphasis on organisms collected from less accessible deep-water marine environments. The primary focus of the project will be to provide compounds that are structurally new to science but in addition to these, rare natural products with unusual structures that are not currently available to the MLSMR will also be provided. All compounds provided will meet the MLSMR's criteria of 10 mg, > 90% purity and solubility in either chloroform:methanol 9:1 or DMSO. HBOI has an exceptional collection of over 15,000 marine organisms that can be used in generation of the pilot-scale library with many of the organisms being unique to the HBOI collection. A recent project conducted by our research group to create a "Peak Library" of enriched fractions compatible with high throughput screening, has been highly successful in detecting unusual chemotypes in organisms which had not been chemically investigated in the past. The majority of the fractions in the Peak Library require only one additional purification step to provide pure materials and the scale of the initial fractionation (medium pressure liquid chromatography) leads readily to the isolation of larger quantities of materials. We have recently expanded the HBOI screening platform and have observed that many of the novel chemotypes found in the Peak Library affect unique biological targets and represent novel lead structures and excellent probes for studying biological processes. We will build upon the methods used to produce our Peak Library to create a unique pilot scale library of pure unusual natural products that expands the chemical diversity space currently available in the MLSMR.
PUBLIC HEALTH RELEVANCE: The proposed research project will provide a unique pilot scale library of new and rare natural products to the Molecular Libraries Small Molecule Repository and expand the chemical diversity of the library. This will enhance the Molecular Roadmap's opportunities for meeting their goal of discovering new probes of biological mechanisms as well as compounds with unique biological activities relative to human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Marine Invertebrate-Derived Antimalarial Agents
-
批准号:8583125
-
项目类别:
-
资助金额:$21.81万
-
财政年份:2013
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Production of Pilot Scale Libraries of Marine Natural Products
-
批准号:7758447
-
项目类别:
-
资助金额:$34.07万
-
财政年份:2010
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Production of Pilot Scale Libraries of Marine Natural Products
-
批准号:8056125
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2010
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Creation of a Marine Natural Products Library to Enhance Life Science Research
-
批准号:7934694
-
项目类别:
-
资助金额:$58.07万
-
财政年份:2009
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
-
批准号:7914808
-
项目类别:
-
资助金额:$14.94万
-
财政年份:2009
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Creation of a Marine Natural Products Library to Enhance Life Science Research
-
批准号:7861971
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2009
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
New Anticancer Agents from Atlantic and Caribbean
-
批准号:6924486
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2005
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
-
批准号:7626984
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
-
批准号:6572826
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
-
批准号:8090437
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
-
批准号:6919987
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
-
批准号:6768672
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
-
批准号:8256540
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
-
批准号:7784741
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2003
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
-
批准号:7656970
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2001
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Actinomycetes from deep sea invertebrates: source of novel biosynthetic genes
-
批准号:6300679
-
项目类别:
-
资助金额:$11.56万
-
财政年份:2000
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
Actinomycetes from deep sea invertebrates: source of novel biosynthetic genes
-
批准号:6222359
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1999
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
New Anticancer Agents from Atlantic and Caribbean Marine Organisms
-
批准号:7630265
-
项目类别:
-
资助金额:$29.27万
-
财政年份:--
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
New Anticancer Agents from Atlantic and Caribbean
-
批准号:7630257
-
项目类别:
-
资助金额:$27.12万
-
财政年份:--
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
New Anticancer Agents from Atlantic and Caribbean Marine Organisms
-
批准号:7630261
-
项目类别:
-
资助金额:$29.82万
-
财政年份:--
-
负责人:AMY Elizabeth WRIGHT
-
依托单位:
海外基金